ESTRO 38 - Programme Book & Exhibition Guide

Astrazeneca Sunday 28 April 2019 | 13:15-14:15 | Brown 3

SUNDAY 28 APRIL 2019

Chemoradiation Followed by Immunotherapy: Transforming the Approach for Treating Unresectable Stage III NSCLC Speakers: Roy Decker, MD, PhD, Radiation Oncologist, Yale Cancer Center, USA Francesco Grossi, MD, Medical Oncologist, Fondazione IRCCS Ca’ Granda Policlinico di Milano, Italy

Shankar Siva, MD, PhD, Radiation Oncologist, Peter MacCallum Cancer Centre, Australia

> Immunotherapy Overview and Importance of Multidisciplinary Care in Stage III NSCLC Faculty: Shankar Siva, MD, PhD, Peter MacCallum Cancer Centre, Australia Treatment for Unresectable Stage III NSCLC: Approaches and Management of CRT Faculty: Roy Decker, MD, PhD, Yale Cancer Center, United States Treatment for Unresectable Stage III NSCLC: Immunotherapy After CRT Faculty: Francesco Grossi, MD, Fondazione IRCCS, Ca’ Granda Policlinico, di Milano, Italy

13:15-13:25

13:25-13:40 >

13:40-14:00 >

Question and Answer session Panel

14:00-14:10 >

Summary and Closing Remarks Faculty: Shankar Siva, MD, PhD, Peter MacCallum Cancer Centre, Australia

14:10-14:15

>

Visit Astrazeneca, booth 5800 for more information

SATELLITE SYMPOSIA | Programme and Exhibition Guide

386